Attached files
| file | filename |
|---|---|
| 10-K - 10-K - HAEMONETICS CORP | fy201610-kdocument.htm |
| EX-32.2 - EXHIBIT 32.2 - HAEMONETICS CORP | fy2016exh322.htm |
| EX-32.1 - EXHIBIT 32.1 - HAEMONETICS CORP | fy2016exh321.htm |
| EX-31.2 - EXHIBIT 31.2 - HAEMONETICS CORP | fy2016exh312.htm |
| EX-31.1 - EXHIBIT 31.1 - HAEMONETICS CORP | fy2016exh311.htm |
| EX-21.1 - EXHIBIT 21.1 - HAEMONETICS CORP | fy2016exh211.htm |
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-200226, 333-181847, 333-136839, 333-149205, and 333-159434) of our reports dated June 1, 2016, with respect to the consolidated financial statements and schedule of Haemonetics Corporation and the effectiveness of internal control over financial reporting of Haemonetics Corporation, included in this Annual Report (Form 10-K) of Haemonetics Corporation for the fiscal year ended April 2, 2016.
/s/ Ernst & Young LLP
Boston, Massachusetts
June 1, 2016